CTH and coronary artery disorder: Future clinical investigations may consider H2S and its related metabolic factors (such as L-cysteine, homocysteine, CSE, CBS, and 3-MST as relevant biomarkers for assessing the prognosis and risk of developing PH from CHD and COPD.